A commonly used class of biologic response modifying drugs can cause acute liver injury with elevated liver enzymes, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...
Apr 29, 2013
0
0
Biosimilars are biologic agents that highly similar to original biomedical medications (originators), but are much cheaper. A new study in Alimentary Pharmacology & Therapeutics found no differences in drug levels and disease ...
Dec 6, 2017
0
0
(HealthDay)—Among biologics used for the treatment of psoriasis, there do not appear to be differential risks for serious infection or respiratory tract infection, according to a study presented at the annual meeting of ...
Oct 8, 2021
0
3
In patients with inflammatory bowel disease (IBD), the body attacks the lining of the digestive tract. Up to half of patients who benefit from the first-line anti-inflammatory drug infliximab eventually stop responding to ...
Oct 3, 2017
0
0
Patients with inflammatory bowel disease (IBD) and high visceral adipose tissue (VAT) may have more difficulty achieving higher infliximab levels necessary to achieve remission, according to a study published in the November ...
Nov 15, 2023
0
0
